Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

[Characteristics and design of the studies evaluating pharmacological interactions].

Montané E, López A, Costa J.

Med Clin (Barc). 2013 Jul 21;141(2):82-6. doi: 10.1016/j.medcli.2013.04.006. Epub 2013 May 22. Spanish. No abstract available.

PMID:
23706685
2.

Evaluation of metabolism-mediated herb-drug interactions.

Na DH, Ji HY, Park EJ, Kim MS, Liu KH, Lee HS.

Arch Pharm Res. 2011 Nov;34(11):1829-42. doi: 10.1007/s12272-011-1105-0. Epub 2011 Dec 3. Review.

PMID:
22139684
3.

Individual response to drug therapy: bases and study approaches.

León-Cachón RB, Ascacio-Martínez JA, Barrera-Saldaña HA.

Rev Invest Clin. 2012 Jul-Aug;64(4):364-76. Review.

PMID:
23227587
4.
5.

[Significance of drug transporter for the internal medicine clinic].

Siegmund W, Cascorbi I, Weitschies W, Kroemer HK.

Internist (Berl). 2003 Feb;44(2):219-26. German. No abstract available.

PMID:
12674742
6.

Role of transporters in drug interactions.

Han HK.

Arch Pharm Res. 2011 Nov;34(11):1865-77. doi: 10.1007/s12272-011-1107-y. Epub 2011 Dec 3. Review.

PMID:
22139686
7.

Distinguishing rational from irrational applications of pharmacogenetic synergies from the bench to clinical trials.

Hucl T, Gallmeier E, Kern SE.

Cell Cycle. 2007 Jun 1;6(11):1336-41. Epub 2007 Jun 27. Review.

PMID:
17568192
8.

Intestinal first-pass metabolism: bridging the gap between in vitro and in vivo.

Galetin A.

Curr Drug Metab. 2007 Oct;8(7):643-4. No abstract available.

PMID:
17979662
9.

Reasons for monitoring kinetics in safety evaluation studies.

Hawkins DR, Chasseaud LF.

Arch Toxicol Suppl. 1985;8:165-72.

PMID:
3868346
10.

Potential role of intestinal first-pass metabolism in the prediction of drug-drug interactions.

Galetin A, Gertz M, Houston JB.

Expert Opin Drug Metab Toxicol. 2008 Jul;4(7):909-22. doi: 10.1517/17425255.4.7.909 . Review.

PMID:
18624679
11.

On the assessment of effects of food on the pharmacokinetics of drugs in early development.

Li Z, Vachharajani NN, Krishna R.

Biopharm Drug Dispos. 2002 May;23(4):165-71. Review.

PMID:
12015791
12.

Preclinical pharmacokinetics and disposition of a novel selective VEGFR inhibitor fruquintinib (HMPL-013) and the prediction of its human pharmacokinetics.

Gu Y, Wang J, Li K, Zhang L, Ren H, Guo L, Sai Y, Zhang W, Su W.

Cancer Chemother Pharmacol. 2014 Jul;74(1):95-115. doi: 10.1007/s00280-014-2471-3. Epub 2014 May 11.

PMID:
24817647
13.

Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein.

Tachibana T, Kato M, Takano J, Sugiyama Y.

Curr Drug Metab. 2010 Nov;11(9):762-77. Review.

PMID:
21189139
14.

Herb-drug interactions: focus on metabolic enzymes and transporters.

Choi YH, Chin YW, Kim YG.

Arch Pharm Res. 2011 Nov;34(11):1843-63. doi: 10.1007/s12272-011-1106-z. Epub 2011 Dec 3. Review.

PMID:
22139685
15.

[Intestinal absorption and renal excretion mediated by transporters and the relationship with drug-drug interaction].

Zhang J, Liu KX.

Yao Xue Xue Bao. 2010 Sep;45(9):1089-94. Review. Chinese.

PMID:
21351563
16.

"Cocktail" approaches and strategies in drug development: valuable tool or flawed science?

Zhou H, Tong Z, McLeod JF.

J Clin Pharmacol. 2004 Feb;44(2):120-34. Review.

PMID:
14747420
17.

P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions.

Kumar YS, Adukondalu D, Sathish D, Vishnu YV, Ramesh G, Latha AB, Reddy PC, Sarangapani M, Rao YM.

Drug Metabol Drug Interact. 2010;25(1-4):3-16. doi: 10.1515/DMDI.2010.006. Review.

PMID:
21417789
18.

Drug-herb interactions: eliminating toxicity with hard drug design.

Yang XX, Hu ZP, Duan W, Zhu YZ, Zhou SF.

Curr Pharm Des. 2006;12(35):4649-64. Review.

PMID:
17168768
19.

Intestinal drug transporter expression and the impact of grapefruit juice in humans.

Glaeser H, Bailey DG, Dresser GK, Gregor JC, Schwarz UI, McGrath JS, Jolicoeur E, Lee W, Leake BF, Tirona RG, Kim RB.

Clin Pharmacol Ther. 2007 Mar;81(3):362-70. Epub 2007 Jan 10.

PMID:
17215845
20.

Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.

Yan Z, Caldwell GW.

Curr Top Med Chem. 2001 Nov;1(5):403-25. Review.

PMID:
11899105

Supplemental Content

Support Center